Decibel Therapeutics is a cutting-edge biotechnology company based in Boston, MA, that focuses on decoding hearing health and developing innovative treatments for hearing loss. Their mission is to revolutionize the field of hearing therapeutics and improve the lives of millions of people worldwide.
Decibel Therapeutics utilizes a multidisciplinary approach, combining genetics, genomics, and drug discovery to uncover the underlying causes of hearing loss. By understanding the genetic factors that contribute to hearing loss, they aim to develop targeted therapies that address the specific needs of individual patients.
One of the key areas of research at Decibel Therapeutics is the identification and development of small molecule drugs that can restore or protect the function of the inner ear. These drugs have the potential to regenerate damaged hair cells, which are essential for hearing, and prevent further hearing loss.
An example of Decibel Therapeutics' groundbreaking work is their collaboration with Regeneron Pharmaceuticals. Together, they are working on developing precision medicines for hearing loss caused by specific genetic mutations. This partnership combines Decibel's expertise in hearing therapeutics with Regeneron's capabilities in genetic research and drug development.
Decibel Therapeutics also actively collaborates with academic institutions, research organizations, and patient advocacy groups to accelerate the discovery and development of new treatments. By fostering collaborations, they can leverage the collective knowledge and resources of the scientific community to advance hearing health research.
References:
Decibel Therapeutics. (n.d.). Retrieved from https://www.decibeltx.com/
Regeneron and Decibel Therapeutics Announce Collaboration to Discover and Develop New Therapies for Hearing Loss and Tinnitus. (2021, March 30). Retrieved from https://www.regeneron.com/newsroom/news/regeneron-and-decibel-therapeutics-announce-collaboration-to-discover-and-develop-new-therapies-for-hearing-loss-and-tinnitus
Decibel Therapeutics is at the forefront of hearing health research, pushing the boundaries of science and technology to unlock new possibilities for individuals with hearing loss. Through their innovative approach and collaborations, they are working towards a future where hearing loss can be effectively treated and managed.

How to Contact Us:
Website: https://www.decibeltx.com/
Twitter: https://twitter.com/decibeltx/
Linkedin: https://www.linkedin.com/company/decibel-therapeutics/
Call us: (617) 370-8701
Address: 1325 Boylston St suite 500, Boston, MA 02215, USA